Next Article in Journal
The Ontario Cancer Research Ethics Board: A Central REB That Works
Previous Article in Journal
Health Management Program: Factors Influencing Completion of Therapy with High-Dose Interferon Alfa-2b for High-Risk Melanoma
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Chinese Medicine and Biomodulation in Cancer Patients—Part One

Departments of Oncology and Medicine, McMaster University, Juravinski Cancer Program, Hamilton Health Sciences Corporation, and The Brain–Body Institute, St. Joseph’s Healthcare System, Hamilton, ON, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2008, 15(1), 42-48; https://doi.org/10.3747/co.2008.197
Submission received: 3 October 2007 / Revised: 6 November 2007 / Accepted: 12 December 2007 / Published: 1 January 2008

Abstract

Traditional Chinese Medicine (tcm) may be integrated with conventional Western medicine to enhance the care of patients with cancer. Although tcm is normally implemented as a whole system, recent reductionist research suggests mechanisms for the effects of acupuncture, herbs, and nutrition within the scientific model of biomedicine. The health model of Chinese medicine accommodates physical and pharmacologic interventions within the framework of a body–mind network. A Cartesian split does not occur within this model, but to allow for scientific exploration within the restrictions of positivism, reductionism, and controls for confounding factors, the components must necessarily be separated. Still, whole-systems research is important to evaluate effectiveness when applying the full model in clinical practice. Scientific analysis provides a mechanistic understanding of the processes that will improve the design of clinical studies and enhance safety. Enough preliminary evidence is available to encourage quality clinical trials to evaluate the efficacy of integrating tcm into Western cancer care.
Keywords: Chinese medicine; herbs; acupuncture; supportive care; immunity; research Chinese medicine; herbs; acupuncture; supportive care; immunity; research

Share and Cite

MDPI and ACS Style

Sagar, S.M.; Wong, R.K. Chinese Medicine and Biomodulation in Cancer Patients—Part One. Curr. Oncol. 2008, 15, 42-48. https://doi.org/10.3747/co.2008.197

AMA Style

Sagar SM, Wong RK. Chinese Medicine and Biomodulation in Cancer Patients—Part One. Current Oncology. 2008; 15(1):42-48. https://doi.org/10.3747/co.2008.197

Chicago/Turabian Style

Sagar, S. M., and R. K. Wong. 2008. "Chinese Medicine and Biomodulation in Cancer Patients—Part One" Current Oncology 15, no. 1: 42-48. https://doi.org/10.3747/co.2008.197

APA Style

Sagar, S. M., & Wong, R. K. (2008). Chinese Medicine and Biomodulation in Cancer Patients—Part One. Current Oncology, 15(1), 42-48. https://doi.org/10.3747/co.2008.197

Article Metrics

Back to TopTop